July 3, 2025

PRESS RELEASE Professor Dressler Receives Honorary Professorship from the Tashkent Medical Academy in Uzbekistan 

Professor Dr Dr Dirk Dressler, Head of the Movement Disorders Section at Hannover Medical School, Hannover, Germany, has been awarded an honorary professorship by Tashkent Medical Academy in Uzbekistan for his contributions to the development of botulinum toxin therapy and his research into dystonia. The award ceremony was held by the Rector of Tashkent Medical…

Show this Post ›
June 18, 2025

Annual Meeting of the Boston Scientific Foundation Europe

End of June the annual meeting of the Boston Scientific Foundation Europe  (BSFE) was held in the Boston Scientific offices in Milan, Italy. BSFE helps communities improve their health and well-being by supporting innovative digital health solutions. The Foundation was established in 2018 with the aim of having an immediate and lasting impact by supporting European non-profit organisations….

Show this Post ›
June 5, 2025

Getting the right care: Physiotherapy for dystonia in the UK

Physiotherapy is an important part of dystonia management, with research demonstrating it can enhance botulinum toxin injection outcomes, helping reduce pain and improving daily functioning. However, in the UK, whilst neurological physiotherapy is recommended in national pathways, patient access remains unclear. Previous research has highlighted challenges in physiotherapy access for dystonia patients, with many only referred if…

Show this Post ›
May 25, 2025

EPF AGM and Leadership Meeting

On 24th and 25th May, EPF (European Patients Forum) held their AGM (Annual General Meeting) in Brussels, Belgium. EPF is an independent, non-profit, non-governmental umbrella organisation of patient organisations across Europe and across disease areas. EPF has 78 members in disease-specific patient groups. EPF is active at EU level and national coalitions of patients. Dystonia…

Show this Post ›